Lombard Odier Asset Management (Switzerland)’s Teva Pharmaceuticals TEVA Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-17,069	Closed	-$210K	–	373
2020 Q2	$210K	Hold	17,069	–	–	0.03%	133
2020 Q1	$153K	Hold	17,069	–	–	0.02%	330
2019 Q4	$167K	Hold	17,069	–	–	0.02%	366
2019 Q3	$117K	Hold	17,069	–	–	0.01%	355
2019 Q2	$158K	Hold	17,069	–	–	0.02%	333
2019 Q1	$268K	Sell	17,069 -67,135	-80%	-$1.18M	0.03%	317
2018 Q4	$1.3M	Buy	84,204 +44,689	+113%	+$916K	0.15%	113
2018 Q3	$851K	Sell	39,515 -6,041	-13%	-$140K	0.08%	194
2018 Q2	$1.11M	Sell	45,556 -6,531	-13%	-$133K	0.12%	166
2018 Q1	$890K	Buy	+52,087	New	+$1.02M	0.09%	194
2015 Q3	–	Sell	-7,194	Closed	-$425K	–	398
2015 Q2	$425K	Sell	7,194 -1,881	-21%	-$116K	0.03%	370
2015 Q1	$570K	Sell	9,075 -7,938	-47%	-$462K	0.06%	287
2014 Q4	$978K	Buy	17,013 +36	+0.2%	+$2.01K	0.11%	149
2014 Q3	$917K	Buy	16,977 +10,733	+172%	+$569K	0.02%	553
2014 Q2	$326K	Buy	+6,244	New	+$319K	0.04%	289

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s TEVA Position: Q3 2020 in Review

Lombard Odier Asset Management (Switzerland) sold out of Teva Pharmaceuticals (TEVA) in Q3 2020, closing a stake of 17,069 shares — an estimated $210K sold.

Lombard Odier Asset Management (Switzerland) first reported a position in TEVA in Q2 2014 and held it in 15 quarters. The position peaked at $1.3M in Q4 2018. 444 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

Lombard Odier Asset Management (Switzerland) reported no remaining Teva Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Lombard Odier Asset Management (Switzerland) sold 17,069 Teva Pharmaceuticals shares in Q3 2020, an estimated $210K.
Lombard Odier Asset Management (Switzerland) first reported a position in Teva Pharmaceuticals in Q2 2014 and held it in 15 quarters.
Lombard Odier Asset Management (Switzerland)'s Teva Pharmaceuticals position peaked at $1.3M in Q4 2018.
444 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q3 2020, filed 16 Nov 2020.